BB
IMGN

BB Biotech’s Immunogen Inc IMGN Stock Holding History

BB Biotech’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,840,816
Closed -$25.4M – 30
2015
Q1 		$25.4M Sell
2,840,816
-400,000
-12% -$2.9M 0.76% 25
2014
Q4 		$19.8M Buy
3,240,816
+75,000
+2% +$686K 0.64% 24
2014
Q3 		$33.5M Hold
3,165,816
– – 1.36% 18
2014
Q2 		$37.5M Hold
3,165,816
– – 1.78% 15
2014
Q1 		$47.3M Sell
3,165,816
-60,000
-2% -$946K 2.44% 14
2013
Q4 		$47.3M Sell
3,225,816
-50,000
-2% -$768K 2.53% 12
2013
Q3 		$55.8M Buy
3,275,816
+13,722
+0.4% +$241K 3.03% 10
2013
Q2 		$54.1M Buy
+3,262,094
New +$52.9M 3.9% 9

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BB Biotech's IMGN Position: Q2 2015 in Review

BB Biotech sold out of Immunogen Inc (IMGN) in Q2 2015, closing a stake of 2,840,816 shares — an estimated $25.4M sold.

BB Biotech first reported a position in IMGN in Q2 2013 and held it in 8 quarters. The position peaked at $55.8M in Q3 2013. 140 funds tracked by Wall St. Rank hold IMGN as of Q2 2015.

  • BB Biotech reported no remaining Immunogen Inc position as of Q2 2015 after selling out during the quarter.
  • BB Biotech sold 2,840,816 Immunogen Inc shares in Q2 2015, an estimated $25.4M.
  • BB Biotech first reported a position in Immunogen Inc in Q2 2013 and held it in 8 quarters.
  • BB Biotech's Immunogen Inc position peaked at $55.8M in Q3 2013.
  • 140 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2015.

Based on BB Biotech's 13F filing for Q2 2015, filed 12 Aug 2015.